Thursday, Mar 28, 2024 | Last Update : 05:55 PM IST

precision cancer drug

Precision cancer therapy works in 75 per cent of patients, says study

Larotrectinib, taken orally once or twice a day, interferes with an on-switch for cancer growth caused by an acquired genetic defect.

22 Feb 2018 8:16 AM

ADVERTISEMENT
ADVERTISEMENT